Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 2019

View Archived Issues

Brain kinase induces spinal cord regeneration

Microfluidics method broadens human iPSC potential

Brain regulatory T cells potentiate neurological recovery

Oppilan Pharma initiates phase I study of OPL-002

Regulus announces clinical candidate nomination for RGLS-5579 for GBM

Oncolys BioPharma initiates phase II study of Telomelysin in combination with pembrolizumab

Patient enrollment begins in phase II study of CPI-613 in Burkitt lymphoma/leukemia

Kymab initiates phase II study of KY-1005 in atopic dermatitis

Patient recruitment ongoing in first-in-human study of IBI-101

Georgia State University describes new carbon monoxide-releasing molecules

Tarlige tablets receive approval in Japan for the treatment of peripheral neuropathic pain

Inovio initiates first-in-human study of DNA-encoded monoclonal antibody for Zika

The General Hospital Corp. patents new CYP1 inhibitors

Combining novel MCL-1 inhibitor with MEK inhibitors as promising new strategy in KRAS-mutant NSCLC

Genentech and Roche disclose IRAK-4 inhibitors

Medshine Discovery presents TLR8 agonists

CX-23, an NQO1-selective activated prodrug of triptolide, shows promise in preclinical models of HCC

Chinese researchers identify compounds for estrogen receptor-mediated diseases

Spero and Everest Medicines sign license and option agreements for SPR-206 and SPR-741 in Asia

Japan first to approve Evenity for osteoporosis

MediciNova opens enrollment in phase I/II study of MN-166 with temozolomide in GBM

Demser approved in Japan to improve catecholamine excess secretion in patients with pheochromocytoma

Japanese approval for Braftovi and Mektovi for unresectable melanoma with BRAF mutation

Wockhardt presents first clinical data for WCK-5222 in patients with renal impairment

IAVI initiates phase I trial of BG505 SOSIP.664 gp140 in HIV-uninfected subjects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...